{"id":"https://genegraph.clinicalgenome.org/r/d3d08594-fb37-414f-bc40-4c6071fddb45v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is one large family with a specific missense mutation (that is otherwise very rare in gnomAD) with a LOD score 2.41 and for which there is extensive functional studies with a Gorlin-like phenotype. The other report is a frameshift variant in a Japanese individual. The Ptch2 mouse knockout model showed related but milder phenotype with no tumors. The evidence that variants in PTCH2 cause a Gorlin-like phenotype (odontogenic cysts, etc) with milder phenotype and lower penetrance than the PTCH1-associated genotype is limited.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d3d08594-fb37-414f-bc40-4c6071fddb45","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-10-12T21:39:08.660Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4d6fa72-4410-446c-b0f6-de0141a5bbd0","type":"EvidenceLine","dc:description":"Homozygous mutant mice, Ptch2-/-, developed normally, were viable and fertile, and did not display any obvious defects in hair follicle, limb, neural, or testis development.  Epidermal hyperplasia of Ptc2-deficient mice never develop into BCC or other skin tumors. Only male mice displayed the phenotypes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8cdf0039-4a04-4cf0-9212-f06479566e42","type":"Finding","dc:description":"Adult Ptch2-/- male animals develop skin lesions consisting of alopecia, ulceration and epidermal hyperplasia, suggesting that normal Ptch2 function is required for adult skin homeostasis. This Ptch2-/- mice phenotype is similar to, but somewhat milder than the phenotype in this family with NBCCS.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16914743","rdfs:label":"Ptc2 mutant mice develop Alopecia and Epidermal Hyperplasia","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8078ce6-46a0-4a59-b22c-86b5a0f7e5b4","type":"EvidenceLine","dc:description":"SUFU-related NBCCS is associated with a high risk for medulloblastoma of up to 33% (3/9) and a high meningioma risk post radiation.\nFacial features are likely more subtle in individuals with an SUFU pathogenic variant.\nOverall, clinical features are milder in individuals with SUFU-related NBCCS with less BCCs, and no jaw cysts reported [Evans et al 2017]. Can consider reduce points.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7f139f8-2d86-46a7-87b3-78e1319d547c","type":"Finding","dc:description":"PTCH2 acts as a receptor for hh signaling.  SUFU is a negative regulator of SHH signaling that interacts with all three GLI proteins and mediates their nuclear export in the absence of SHH [Dunaeva et al., 2003].","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19533801","rdfs:label":"SUFU, a negative regulator in hh signaling related to NBCCS","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/82253e55-445f-4f7a-bc1f-294bca34cf34","type":"EvidenceLine","dc:description":"PTCH1 and PTCH2 are two patched receptors functioning in hh signaling","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9cedd5b8-97bc-4e2e-b44c-7f4dc4cc60a9","type":"Finding","dc:description":"Binding analysis shows that both PTCH1 and PTCH2 can interact with all HH family members with similar affinity, and form a complex with SMO.  Suppression of hair-follicle development inhibits induction of Shh, Ptch1 and Ptch2 in hair germs in mice. Loss of Ptch2 markedly promotes tumour formation in combination with Ptch1 haploinsufficiency.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","rdfs:label":"PTCH1 cause dominantly inherited NBCCS","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa20b4e5-1bce-483d-93f5-1d4acb8fbed7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A heterozygous 2-base-pair deletion, c.1172_1173delCT, was detected in exon 9 of PTCH2 (Fig. 2). This mutation caused a frameshift and created a premature termination codon (PTC) p.S391X.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12a0b1d4-5b88-4a14-98b1-55abb216cf39","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23479190","rdfs:label":"a 13-year-old Japanese girl","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000892","obo:HP_0010603"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fa20b4e5-1bce-483d-93f5-1d4acb8fbed7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23479190","allele":{"id":"https://genegraph.clinicalgenome.org/r/866b28b4-4b66-439e-9741-94e0344c4738","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001166292.1(PTCH2):c.1172_1173delCT (p.Ser391Terfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6145"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12359f6f-575a-4bd3-b297-03b26a6a2ba3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"(1) PTCH2-R719Q failed to suppress GLI reporter activity (Fig 4A).\n(2) Overexpression of wild-type PTCH2 significantly inhibited cell growth compared with the control vector. In contrast, PTCH2-R719Q-expressing cells grew at a similar rate to the control cells (Fig 4B).\n(3) Western blot analysis revealed that the expression of cyclin D1 was significantly reduced in wild-type PTCH2-expressing cells compared with control cells, whereas there was no difference between PTCH2-R719Q-expressing cells and control cells (fig 4C).\nThree in vitro functional evidences provided, so increase to 1 point.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9856dfdf-b05e-48cd-a8b9-4ca0160e496f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18285427","rdfs:label":"IV:11","ageType":"AgeAtReport","ageUnit":"Years","ageValue":25,"detectionMethod":"Direct sequencing and digestion with the AvaI restriction enzyme","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000892","obo:HP_0010610","obo:HP_0010603","obo:HP_0002671"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/12359f6f-575a-4bd3-b297-03b26a6a2ba3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18285427","allele":{"id":"https://genegraph.clinicalgenome.org/r/ff979896-e086-4878-b114-80cbf32049d8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001166292.1(PTCH2):c.2156G>A (p.Arg719Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6147"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d189ca00-ba80-49af-9b2e-8523c8d29a44_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/50c90282-d0ae-43a6-9981-af9224599546_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18285427","rdfs:label":"a Chinese family","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/50c90282-d0ae-43a6-9981-af9224599546","type":"Family","rdfs:label":"a Chinese family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9856dfdf-b05e-48cd-a8b9-4ca0160e496f"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":9,"phenotypes":["obo:HP_0002671","obo:HP_0010610","obo:HP_0010603","obo:HP_0000892"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9856dfdf-b05e-48cd-a8b9-4ca0160e496f"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Limited","sequence":34,"specifiedBy":"GeneValidityCriteria6","strengthScore":5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/nESv48U2OS0","type":"GeneValidityProposition","disease":"obo:MONDO_0007187","gene":"hgnc:9586","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d189ca00-ba80-49af-9b2e-8523c8d29a44-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}